Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance

Key Points

• The aim is to investigate dermoscopic and histopathological changes in melanocytic nevi among patients receiving vandetanib.
• Analyzed dermoscopic features and histopathological alterations in melanocytic nevi.
• Focused on patients undergoing oncologic therapy, particularly vandetanib.
• Notable regression-like changes observed in multiple melanocytic nevi during treatment.
• Findings suggest potential implications for increased dermatological surveillance in these patients.